MTOR and neoplasm: It is caused by mutations in either the TSC1 or TSC2 gene, which result in upregulation of the mammalian target of rapamycin (mTOR) pathway and subsequent tumor growth in various organs such as the brain, heart, skin, eyes, kidney, lung, and liver [2, 3].